Clinical Trial Update: An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tiotropium as add-on therapy in severe persistent asthma shows efficacy and safety results. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED